Effect of diet on brain metabolites and behavior in spontaneously hypertensive rats

Behavioural Brain Research

Volumn 270, Issue , 2014, Pages 240-247

  Liso Navarro, Ana A ^a,d   Sikoglu, Elif M ^a   Heinze, Cailin R ^b   Rogan, Ryan C ^a   Russell, Vivienne A ^c   King, Jean A ^a   Moore, Constance M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

ADHD; Energy metabolism; Fatty acid; Neuroimaging; Rat

Indexed keywords

CHOLINE; CREATININE; GLUTAMIC ACID; INOSITOL; LACTIC ACID; N ACETYLASPARTIC ACID; OMEGA 3 FATTY ACID; ASPARTIC ACID; CREATINE; FAT INTAKE; FISH OIL; N-ACETYLASPARTATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DIETARY INTAKE; ELEVATED PLUS MAZE TEST; ENERGY METABOLISM; FRONTAL LOBE; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TASK PERFORMANCE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; BRAIN; DIET THERAPY; DISEASE MODEL; DRUG EFFECTS; FAT INTAKE; HIGH RISK BEHAVIOR; MAZE TEST; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; THERAPEUTIC USE;

ANIMALS; ASPARTIC ACID; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CREATINE; DIETARY FATS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FISH OILS; FRONTAL LOBE; GLUTAMIC ACID; LOCOMOTION; MALE; MAZE LEARNING; MOTOR ACTIVITY; PROTON MAGNETIC RESONANCE SPECTROSCOPY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, INBRED SHR; RISK-TAKING;

EID: 84901649683     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.05.013     Document Type: Article

References (72)

1. Biederman J., Faraone S.V. Attention-deficit hyperactivity disorder. Lancet 2005, 366:237-248.
2. Curatolo P., Paloscia C., D'Agati E., Moavero R., Pasini A. The neurobiology of attention deficit/hyperactivity disorder. Eur J Paediatr Neurol 2009, 13:299-304.
3. Russell V.A., Oades R.D., Tannock R., Killeen P.R., Auerbach J.G., Johansen E.B., et al. Response variability in attention-deficit/hyperactivity disorder: a neuronal and glial energetics hypothesis. Behav Brain Funct 2006, 2:30.
4. Todd R.D., Botteron K.N. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome. Biol Psychiatry 2001, 50:151-158.
5. Lesch K.P., Merker S., Reif A., Novak M. Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD. Eur Neuropsychopharmacol 2013, 23:479-491.
6. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA 1994, 91:10625-10629.
7. Macmaster F., Carrey N., Sparkes S., Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 2003, 53:184-187.
8. Courvoisie H., Hooper S.R., Fine C., Kwock L., Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 2004, 16:63-69.
9. Carrey N.J., MacMaster F.P., Gaudet L., Schmidt M.H. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007, 17:11-17.
10. Wiles N.J., Northstone K., Emmett P., Lewis G. 'Junk food' diet and childhood behavioural problems: results from the ALSPAC cohort. Eur J Clin Nutr 2009, 63:491-498.
11. Howard A.L., Robinson M., Smith G.J., Ambrosini G.L., Piek J.P., Oddy W.H. ADHD is associated with a "Western" dietary pattern in adolescents. J Atten Disord 2011, 15:403-411.
12. McNamara R.K., Carlson S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot Essent Fatty Acids 2006, 75:329-349.
13. Antalis C.J., Stevens L.J., Campbell M., Pazdro R., Ericson K., Burgess J.R. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2006, 75:299-308.
14. Richardson A.J., Puri B.K. The potential role of fatty acids in attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2000, 63:79-87.
15. Colter A.L., Cutler C., Meckling K.A. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study. Nutr J 2008, 7:8.
16. Borsonelo E.C., Galduroz J.C. The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions. Prostaglandins Leukot Essent Fatty Acids 2008, 78:237-245.
17. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006, 75:259-269.
18. Levant B., Radel J.D., Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav Brain Res 2004, 152:49-57.
19. Bloch M.H., Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011, 50:991-1000.
20. Sagvolden T., Johansen E.B., Woien G., Walaas S.I., Storm-Mathisen J., Bergersen L.H., et al. The spontaneously hypertensive rat model of ADHD - the importance of selecting the appropriate reference strain. Neuropharmacology 2009, 57:619-626.
21. Russell V.A. Overview of animal models of attention deficit hyperactivity disorder (ADHD). Curr Protoc Neurosci 2011, Chapter 9, Unit 9.35.
22. Russell V.A. Reprint of "Neurobiology of animal models of attention-deficit hyperactivity disorder". J Neurosci Methods 2007, 166:I-XIV.
23. Wickens J.R., Hyland B.I., Tripp G. Animal models to guide clinical drug development in ADHD: lost in translation?. Br J Pharmacol 2011, 164(4):1107-1128.
24. Sagvolden T., Russell V.A., Aase H., Johansen E.B., Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1239-1247.
25. Sontag T.A., Tucha O., Walitza S., Lange K.W. Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review. Atten Defic Hyperact Disord 2010, 2:1-20.
26. Wei J.W., Yang L.M., Sun S.H., Chiang C.L. Phospholipids and fatty acid profile of brain synaptosomal membrane from normotensive and hypertensive rats. Int J Biochem 1987, 19:1225-1228.
27. Liston C., Malter Cohen M., Teslovich T., Levenson D., Casey B.J. Atypical prefrontal connectivity in attention-deficit/hyperactivity disorder: pathway to disease or pathological end point?. Biol Psychiatry 2011, 69(12):1168-1177.
28. Durston S., van Belle J., de Zeeuw P. Differentiating frontostriatal and fronto-cerebellar circuits in attention-deficit/hyperactivity disorder. Biol Psychiatry 2011, 69:1178-1184.
29. Bush G. Cingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorder. Biol Psychiatry 2011, 69(12):1160-1167.
30. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001, 14:260-264.
31. Hirashima F., Parow A.M., Stoll A.L., Demopulos C.M., Damico K.E., Rohan M.L., et al. Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder. Am J Psychiatry 2004, 161:1922-1924.
32. Sleator E.K., Ullmann R.K. Can the physician diagnose hyperactivity in the office?. Pediatrics 1981, 67:13-17.
33. Russell S.J., McVeigh J. Next generation challenges: an overview of harm reduction 2010, IHRA's 21st conference. Int J Drug Policy 2011, 22:82-86.
34. Cortese B.M., Mitchell T.R., Galloway M.P., Prevost K.E., Fang J., Moore G.J., et al. Region-specific alteration in brain glutamate: possible relationship to risk-taking behavior. Physiol Behav 2010, 99:445-450.
35. Davis J.F., Krause E.G., Melhorn S.J., Sakai R.R., Benoit S.C. Dominant rats are natural risk takers and display increased motivation for food reward. Neuroscience 2009, 162:23-30.
36. Lofgren M., Johansson I.M., Meyerson B., Turkmen S., Backstrom T. Withdrawal effects from progesterone and estradiol relate to individual risk-taking and explorative behavior in female rats. Physiol Behav 2009, 96:91-97.
37. Mikics E., Barsy B., Barsvari B., Haller J. Behavioral specificity of non-genomic glucocorticoid effects in rats: effects on risk assessment in the elevated plus-maze and the open-field. Horm Behav 2005, 48:152-162.
38. Langen B., Dost R. Comparison of SHR, WKY and Wistar rats in different behavioural animal models: effect of dopamine D1 and alpha2 agonists. Atten Defic Hyperact Disord 2011, 3:1-12.
39. Howells F.M., Bindewald L., Russell V.A. Cross-fostering does not alter the neurochemistry or behavior of spontaneously hypertensive rats. Behav Brain Funct 2009, 5:24.
40. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000, 80:1107-1213.
41. Wallimann T., Wyss M., Brdiczka D., Nicolay K., Eppenberger H.M. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992, 281(Pt. 1):21-40.
42. Brewer G.J., Wallimann T.W. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 2000, 74:1968-1978.
43. Joardar A., Sen A.K., Das S. Docosahexaenoic acid facilitates cell maturation and beta-adrenergic transmission in astrocytes. J Lipid Res 2006, 47:571-581.
44. Soliva J.C., Moreno A., Fauquet J., Bielsa A., Carmona S., Gispert J.D., et al. Cerebellar neurometabolite abnormalities in pediatric attention/deficit hyperactivity disorder: a proton MR spectroscopic study. Neurosci Lett 2010, 470:60-64.
45. Pliszka S.R. The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1385-1390.
46. Yang P., Wu M.T., Dung S.S., Ko C.W. Short-TE proton magnetic resonance spectroscopy investigation in adolescents with attention-deficit hyperactivity disorder. Psychiatry Res 2010, 181:199-203.
47. Uauy R., Mena P., Rojas C. Essential fatty acids in early life: structural and functional role. Proc Nutr Soc 2000, 59:3-15.
48. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000, 32:1-14.
49. Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003, 48:195-203.
50. +-ATPase isoenzymes of brain membranes in the adult rat. J Nutr Biochem 1999, 10:230-236.
51. Dervola K.S., Roberg B.A., Woien G., Bogen I.L., Sandvik T.H., Sagvolden T., et al. Marine omicron-3 polyunsaturated fatty acids induce sex-specific changes in reinforcer-controlled behaviour and neurotransmitter metabolism in a spontaneously hypertensive rat model of ADHD. Behav Brain Funct 2012, 8:56.
52. Moore C.M., Biederman J., Wozniak J., Mick E., Aleardi M., Wardrop M., et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 2006, 163:316-318.
53. Wiguna T., Guerrero A.P., Wibisono S., Sastroasmoro S. Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS). Clin Neuropharmacol 2012, 35:81-85.
54. Carrey N., MacMaster F.P., Fogel J., Sparkes S., Waschbusch D., Sullivan S., et al. Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study. Clin Neuropharmacol 2003, 26:218-221.
55. Moore C.M., Breeze J.L., Gruber S.A., Babb S.M., Frederick B.B., Villafuerte R.A., et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2000, 2:207-216.
56. Cecil K.M. Proton magnetic resonance spectroscopy: technique for the neuroradiologist. Neuroimaging Clin N Am 2013, 23:381-392.
57. Tafazoli S., O'Neill J., Bejjani A., Ly R., Salamon N., Mccracken J.T., et al. 1H MRSI of middle frontal gyrus in pediatric ADHD. J Psychiatr Res 2013, 47:505-512.
58. Jin Z., Zang Y.F., Zeng Y.W., Zhang L., Wang Y.F. Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study. Neurosci Lett 2001, 315:45-48.
59. Stanley J.A., Kipp H., Greisenegger E., MacMaster F.P., Panchalingam K., Pettegrew J.W., et al. Regionally specific alterations in membrane phospholipids in children with ADHD: an in vivo 31P spectroscopy study. Psychiatry Res 2006, 148:217-221.
60. Bertholdo D., Watcharakorn A., Castillo M. Brain proton magnetic resonance spectroscopy: introduction and overview. Neuroimaging Clin N Am 2013, 23:359-380.
61. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol 2010, 119:7-35.
62. Donev R., Thome J. Inflammation: good or bad for ADHD. Atten Defic Hyperact Disord 2010, 2:257-266.
63. Buske-Kirschbaum A., Schmitt J., Plessow F., Romanos M., Weidinger S., Roessner V. Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology 2013, 38:12-23.
64. Gupta S., Knight A.G., Keller J.N., Bruce-Keller A.J. Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem 2012, 120:1060-1071.
65. Ramos Olazagasti M.A., Klein R.G., Mannuzza S., Belsky E.R., Hutchison J.A., Lashua-Shriftman E.C., et al. Does childhood attention-deficit/hyperactivity disorder predict risk-taking and medical illnesses in adulthood?. J Am Acad Child Adolesc Psychiatry 2013, 52:153 e4-162 e4.
66. Barkley R.A., Fischer M., Smallish L., Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006, 45:192-202.
67. Killeen P.R., Russell V.A., Sergeant J.A. A behavioral neuroenergetics theory of ADHD. Neurosci Biobehav Rev 2013, 37:625-657.
68. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007, 81:89-131.
69. Morgan J.J., Kleven G.A., Tulbert C.D., Olson J., Horita D.A., Ronca A.E. Longitudinal (1)H MRS of rat forebrain from infancy to adulthood reveals adolescence as a distinctive phase of neurometabolite development. NMR Biomed 2013, 26(6):683-691.
70. Kodas E., Vancassel S., Lejeune B., Guilloteau D., Chalon S. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J Lipid Res 2002, 43:1209-1219.
71. Meneses A., Perez-Garcia G., Ponce-Lopez T., Tellez R., Gallegos-Cari A., Castillo C. Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview. Rev Neurosci 2011, 22(3):365-371.
72. Tayebati S.K., Tomassoni D., Amenta F. Spontaneously hypertensive rat as a model of vascular brain disorder: microanatomy, neurochemistry and behavior. J Neurol Sci 2012, 322:241-249.